VersaPharm Overview

  • Founded
  • 1994
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 6
  • Investments
  • 2

VersaPharm General Information

Description

Developer and marketer of specialty prescription products in the United States. The company offers pharmaceuticals primarily for the treatment areas of tuberculosis, hemophilia, anthrax, parkinsonism, blood disorders and other diseases. It supplies its products through public health departments, wholesale drug networks, managed care providers, hospitals, convalescent homes and retail pharmacies, as well as through federal, state, city and county governments.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 1775 West Oak Parkway
  • Suite 800
  • Marietta, GA 30062
  • United States
+1 (770) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VersaPharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore VersaPharm‘s full profile, request access.

Request a free trial

VersaPharm Executive Team (3)

Name Title Board Seat Contact Info
Kevin Connelly Chief Executive Officer
Stephen McCune Chief Sales & Marketing Officer
Joseph Leary Chief Operating Officer
To view VersaPharm’s complete executive team members history, request access »

VersaPharm Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore VersaPharm‘s full profile, request access.

Request a free trial

VersaPharm Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (000000 0 01-Aug-2012 0000000000 Buildings and Property
Allan Pharmaceuticals (Generic Rx Division) 08-Dec-2008 Buyout/LBO Pharmaceuticals 00000 00000000
To view VersaPharm’s complete investments history, request access »